KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Common Equity: 2010-2025

Historic Common Equity for Exelixis (EXEL) over the last 15 years, with Oct 2025 value amounting to $2.2 billion.

  • Exelixis' Common Equity fell 5.04% to $2.2 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $2.2 billion, marking a year-over-year decrease of 5.04%. This contributed to the annual value of $2.2 billion for FY2025, which is 0.87% down from last year.
  • Per Exelixis' latest filing, its Common Equity stood at $2.2 billion for Q4 2025, which was up 6.25% from $2.0 billion recorded in Q3 2025.
  • Exelixis' 5-year Common Equity high stood at $2.6 billion for Q1 2023, and its period low was $1.9 billion during Q1 2021.
  • Moreover, its 3-year median value for Common Equity was $2.2 billion (2025), whereas its average is $2.3 billion.
  • Its Common Equity has fluctuated over the past 5 years, first increased by 20.02% in 2022, then fell by 16.72% in 2024.
  • Exelixis' Common Equity (Quarterly) stood at $2.2 billion in 2021, then increased by 12.57% to $2.5 billion in 2022, then declined by 9.02% to $2.3 billion in 2023, then declined by 3.08% to $2.3 billion in 2024, then dropped by 5.04% to $2.2 billion in 2025.
  • Its last three reported values are $2.2 billion in Q4 2025, $2.0 billion for Q3 2025, and $2.1 billion during Q2 2025.